Equillium (EQ) Change in Account Payables (2018 - 2026)
Equillium (EQ) posted quarterly Change in Account Payables of $434000.0 for Q1 2026, up 13.91% year-over-year from $381000.0 in Q1 2025, and up 1415.15% quarter-over-quarter from -$33000.0 in Q4 2025.
Equillium (EQ) Change in Account Payables (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Change in Account Payables for 9 consecutive years, with $434000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 13.91% year-over-year to $434000.0; the TTM figure through Mar 2026 stood at -$1.9 million (down 646.09% YoY), while the FY2025 annual figure was -$1.9 million, up 2.91% from the prior year.
- Change in Account Payables improved to $434000.0 in Q1 2026 per EQ's latest filing, from -$33000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.7 million in Q1 2022 and bottomed at -$4.0 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$15705.9 across 5 years, with a median of $434000.0 in 2026.
- On a YoY basis, Change in Account Payables climbed as much as 650.51% in 2022 and fell as far as 401.38% in 2022.
- Equillium's Change in Account Payables stood at $1.5 million in 2022, then slumped by 30.17% to $1.0 million in 2023, then slumped by 190.73% to -$949000.0 in 2024, then soared by 96.52% to -$33000.0 in 2025, then jumped by 1415.15% to $434000.0 in 2026.
- Business Quant data shows EQ's Change in Account Payables at $434000.0 in Q1 2026, -$33000.0 in Q4 2025, and -$4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | -345,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -345,000.00 |
| Jun 30, 2026 | -345,000.00 |
| Mar 31, 2026 | 434,000.00 |
| Mar 31, 2026 | 434,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -4.03 Mn |
| Sep 30, 2025 | -4.03 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 381,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.96 Mn |